Review: Improving the therapeutic index of 8-aminoquinolines by the use of drug combinations: review of the literature and proposal for future investigations.
Hla Y Myint, Jonathan Berman, Larry Walker, Brandon Pybus, Victor Melendez, J Kevin Baird, Colin Ohrt
Index: Am. J. Trop. Med. Hyg. 85(6) , 1010-4, (2011)
Full Text: HTML
Abstract
Because 8-aminoquinolines affect critical survival stages of Plasmodium parasites, treatment and control of malaria could be markedly improved by more widespread use of these drugs; however, hemolytic toxicity, which is widely prevalent in G6PD-deficient patients, severely constrains this use. Primaquine was approved more than 50 years ago after extensive clinical testing. Review of the mid-20th century literature in the light of present understanding of pharmacokinetics and metabolism suggests that manipulation of these factors might dissociate 8-aminoquinoline efficacy from toxicity and lead to an improved therapeutic index.
Related Compounds
Related Articles:
2012-01-01
[Malaria Journal 11 , 259, (2012)]
2012-08-01
[Biol. Chem. 393(8) , 757-65, (2012)]
2012-01-01
[PLoS ONE 7(8) , e43105, (2012)]
2013-10-22
[Proc. Natl. Acad. Sci. U. S. A. 110(43) , 17486-91, (2013)]
[Asian Pac. J. Trop. Med. 5(6) , 485-97, (2012)]